Apogee Therapeutics Inc.
40.38
1.04 (2.64%)
At close: Jan 15, 2025, 1:54 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22
Cash & Equivalents 118.32M 151.89M
Short-Term Investments 277.14M n/a
Long-Term Investments n/a n/a
Other Long-Term Assets 401.00K n/a
Receivables n/a n/a
Inventory n/a n/a
Other Current Assets 2.95M 165.00K
Total Current Assets 398.41M 152.06M
Property-Plant & Equipment 2.59M n/a
Goodwill & Intangibles n/a n/a
Total Long-Term Assets 3.00M n/a
Total Assets 401.40M 152.06M
Account Payables 2.14M 418.00K
Deferred Revenue n/a n/a
Short-Term Debt 1.10M n/a
Other Current Liabilities 17.31M 9.56M
Total Current Liabilities 20.56M 9.98M
Long-Term Debt 933.00K n/a
Other Long-Term Liabilities n/a n/a
Total Long-Term Liabilities 933.00K n/a
Total Liabilities 21.49M 9.98M
Total Debt 2.03M n/a
Common Stock n/a 4.39M
Retained Earnings -123.77M -39.78M
Comprehensive Income 329.00K -221.65M
Shareholders Equity 379.91M -39.78M
Total Investments 277.14M n/a